200 top medical experts on Thiamine responsive megaloblastic anemia syndrome across 25 countries and 5 U.S. states, including 17 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Thiamine responsive megaloblastic anemia syndrome: Thiamine-responsive megaloblastic anemia (TRMA) is characterized by a triad of megaloblastic anemia, non-type I diabetes mellitus, and sensorineural deafness.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Support Organizations

Organizations Providing General Support

  • Synonyms: Abboud syndrome,  With Diabetes Mellitus And Sensorineural Deafness Thiamine-Responsive Megaloblastic Anemia,  Rogers syndrome,  Thiamine responsive myelodysplasia,  Thiamine-Responsive Anemia Syndrome,  Thiamine-Responsive Megaloblastic Anemia Syndrome,  Thiamine-Responsive Myelodysplasia

  •   

            

                        


      Computing Expert Listing ...